Antares Pharma, Inc.
(NASDAQ : ATRS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-0.68%109.630.6%$525.14m
TMOThermo Fisher Scientific Inc.
0.87%297.531.0%$389.25m
ABTAbbott Laboratories
-1.12%84.260.8%$333.53m
ISRGIntuitive Surgical, Inc.
0.02%523.222.4%$312.16m
BDXBecton, Dickinson and Company
-0.57%260.671.1%$233.40m
ALGNAlign Technology, Inc.
1.63%177.476.3%$208.70m
EWEdwards Lifesciences Corporation
-0.43%219.511.2%$208.01m
BSXBoston Scientific Corporation
-0.99%41.821.1%$192.19m
SYKStryker Corporation
-0.94%217.981.3%$189.38m
BAXBaxter International Inc.
-1.05%86.901.7%$177.58m
PODDInsulet Corporation
-0.89%143.246.9%$155.20m
DXCMDexCom, Inc.
-0.61%146.268.3%$137.20m
ZBHZimmer Biomet Holdings, Inc.
-2.68%138.791.7%$126.21m
WATWaters Corporation
-0.29%232.114.0%$110.71m
COOCooper Companies, Inc.
-1.12%301.582.2%$101.20m

Company Profile

Antares Pharma, Inc. engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its proprietary products include XYOSTED (testosterone enanthate) injection, OTREXUP (methotrexate) injection for subcutaneous use, and Sumatriptan Injection. The company was founded in February 1979 and is headquartered in Ewing, NJ.